Clinical Trial Update: Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the safety and efficacy of two Allergan investigational eye-drop candidates, AGN-199201 and AGN-190584, in adults with presbyopia. Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• AGN-190584
• AGN-199201

Snippet

Sponsor: Allergan | Conditions: Presbyopia | Phase 2 | Status: COMPLETED | Results posted: 2015-12-03